Macrophages, TGF-β1 expression and iron deposition in development of NASH
Ananiev Julian +3 more
doaj +1 more source
Prevalence and Risk Factors of Celiac Disease in Patients With Non-Alcoholic Fatty Liver Disease: A Meta-Analysis. [PDF]
Keetha NR +10 more
europepmc +1 more source
Urea cycle dysregulation and arginine pathways in the pathogenesis of NAFLD and NASH (Review). [PDF]
Zhu B +6 more
europepmc +1 more source
Background: This study estimated utility values for non-alcoholic steatohepatitis (NASH). Previous studies have assumed that health-related quality of life does not vary between the early stages of NASH.
Daniel Aggio +4 more
doaj +1 more source
ANTICIPATE-ing a future without liver biopsy in MASH. Ready for prime time? [PDF]
Elangovan H, George J.
europepmc +1 more source
Hematological abnormalities in clinically diagnosed non-alcoholic steatohepatitis: prevalence, clinical correlates, and fibrosis risk in a case-control study from Qatar. [PDF]
Al-Khinji A +5 more
europepmc +1 more source
Causal insights into how NAFLD progression drives abdominal aortic aneurysm: A bidirectional MR study integrating genetic and multi-omics profiling. [PDF]
Xi R +6 more
europepmc +1 more source
Ambrisentan Exhibits Hepatoprotective Effects Against NASH-Associated Hepatic Injury in Dexamethasone-Treated Rats Through Regulation of Inflammation, Ferroptosis and Autophagy. [PDF]
Alharbi NS +3 more
europepmc +1 more source
Histologic severity is identical between normal weight and overweight adults with MASLD: Implications for the definition of lean MASLD. [PDF]
Miller K +7 more
europepmc +1 more source
Multivariate time-series forecasting of liver biomarkers from longitudinal lifestyle data for nonalcoholic steatohepatitis detection. [PDF]
Mila SA, Ray S.
europepmc +1 more source

